ArticlePDF Available

Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma

Authors:
  • Hanoi Medical University Hospital
  • Hanoi Medical University Hospital, Vietnam, hanoi
  • Vietnam National Cancer Hospital

Abstract and Figures

Background: The transoral endoscopic thyroidectomy by vestibular approach (TOETVA) has been developed for thyroid microcarcinoma (TMC) treatment worldwide, with low rate of complications and excellent oncological results. However, this approach has still not been routinely performed. Thus, in this study, we aim to demonstrate the feasibility and safety of this technique in the clinical practice. Methods: In this prospective cohort study, 29 patients diagnosed TMC and clinically node negative underwent thyroidectomy and prophylactic central lymph node dissection by TOETVA. The clinicopathologic characteristics, surgical outcomes, and cosmetic results were evaluated. Results: The mean age was 34.7 ± 8.5 years. Three patients had underlying Grave's disease. Thyroid lobectomy with isthmusectomy was performed in the majority of cases (72.4%). All patients underwent prophylactic central node dissection. The mean number of retrieved central node was 7.8 ± 3.7 (3-19). Seven patients (24.1%) had lymph node metastasis in postoperative pathology. Among them, the mean number of metastatic lymph nodes was 2.1 ± 1.7 (1-5). The mean operative time was 121.2 ± 22.6 minutes. Four patients experienced transient hoarse and 1 patient had hematoma. Visual analog scale score on first postoperative day was 2.8 ± 1.4 (0-5). Most of patients were satisfied with cosmetic outcome. Conclusions: The TOETVA is new technique for TMC in Vietnam. The initial results of oncology, postoperative complications, and cosmetic supported the application of TOETVA in TMC.
Content may be subject to copyright.
Full Report
Comparison of Transoral Thyroidectomy Vestibular
Approach and Unilateral Axillobreast Approach
for Endoscopic Thyroidectomy:
A Prospective Cohort Study
Hau XuanAU1 cNguyen, MD, PhD,
1,2
Long Thanh Nguyen, MD,
1
Hung Van Nguyen, MD, MSc,
2
Hien Xuan Nguyen, MD, MSc,
1
Huy Le Trinh, MD, PhD,
1,2
Tuan Xuan Nguyen, MD, MSc,
3
and Quang Van Le, MD, PhD
1,2
Abstract
Background: Various approaches for endoscopic thyroidectomy have been developed recently that improve the
cosmetic outcome, and some are even scar free. In this study, we compared the safety and surgical outcomes of
transoral endoscopic thyroidectomy vestibular approach (TOETVA) and unilateral axillobreast approach
(UABA) thyroid surgery performed by a single surgeon.
Materials and Methods: We conducted a prospective cohort study among 101 patients undergoing endoscopic
thyroidectomy from 2018 to 2019 in our institution. The factors analyzed included patients’ clinical charac-
teristics, types and time of operation, blood loss, hospital stay, postoperative complications, and cosmetic
satisfaction.
Results: Among 101 patients, 51 underwent TOETVA and 50 had UABA surgery. UABA has shorter operative
time for lobectomy (91.7 16.5 minutes versus 50.4 6.8 minutes, P<.001), whereas TOETVA is associated
with less postoperative pain (
AU3 cVAS score day 1 of 4.6 1.0 versus 5.8 1.0, P<.001). There were no significant
differences between TOETVA and UABA groups regarding rates of transient recurrent laryngeal nerve injury
(9.8% versus 2.0%, P=.205) and hypothyroidism (11.5% versus 2.0%, P=.112), in which all patients fully
recovered 6 months after surgery and most of them were satisfied with the cosmetic result.
Conclusions: Both TOETVA and UABA have been shown to be effective and safe surgical options for
endoscopic thyroid surgery, as well as gave excellent cosmetic result. Each approach has its own advantages
and disadvantages, and choice of technique should be tailored for each individual, and patient preference should
be integrated in the treatment plan.
Keywords: endoscopic thyroidectomy, unilateral axillobreast approach, transoral endoscopic thyroidectomy
vestibular approach, thyroid nodule
Introduction
F
AU4 cor a long time, open thyroidectomy has been the stan-
dard surgical approach for thyroid diseases, but it still
leaves a visible scar in the neck that is of concern to many
patients. Recently, various endoscopic and robotic thyroid-
ectomy techniques have been developed to provide mini-
mally invasive surgery options and improve the cosmetic
outcome without altering the treatment efficacy.
1–3
Among
these, endoscopic thyroidectomy is more suitable for
resource-limited settings due to the high cost and facility
requirement of robotic surgery. Endoscopic surgery could
be performed through various remote-access approaches to
move the scars to other parts of the body such as the axilla,
breast, or postauricular area, and each approach has its own
advantages and disadvantages.
4–6
In Vietnam, the unilateral
1
D
AU2 cepartment of Oncology, Hanoi Medical University, Hanoi, Viet Nam.
2
Department of Oncology and Palliative Care, Hanoi Medical University Hospital, Hanoi, Viet Nam.
3
Department of Oncology, Thanh Nhan Hospital, Hanoi, Viet Nam.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
Volume 00, Number 00, 2020
ªMary Ann Liebert, Inc.
DOI: 10.1089/lap.2020.0272
1
LAP-2020-0272-ver9-Nguyen_1P
Type: research-article
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 1
axillobreast approach (UABA), in which trocars are inserted
through three small incisions in the axilla and breast areola,
has been implemented and has become increasingly popular.
AU5 cThis endoscopic approach provides a convenient operative
space and the small scars are easily hidden and hardly no-
ticeable, and a preliminary report on 50 cases showed
promising results in terms of safety and patient satisfaction.
7
However, it is difficult to perform in males and does not
facilitate total thyroidectomy.
8
Moreover, UABA and espe-
cially bilateral axillobreast approach (BABA) endoscopic
thyroidectomy that allows total thyroidectomy require a large
amount of flap dissection on the anterior chest and still leave
cutaneous scars.
8,9
Since 2008, natural orifice transluminal endoscopic sur-
gery (NOTES) has been applied for thyroidectomy through
oral cavity that completely avoids visible scarring.
10,11
The
transoral endoscopic thyroidectomy vestibular approach
(TOETVA) technique that utilizes three ports on the lower
lip has been developed and only requires a smaller area of
flap dissection compared with UABA as well as provides a
suitable operative view for total thyroidectomy.
12
This
method has been shown to be safe for selected patients in
initial reports.
3,13
However, to our best knowledge, there
have been no data comparing the efficacy and safety of
UABA and TOETVA approaches. In our institution, a single
surgeon has experience in both UABA and TOETVA tech-
niques, in which he has adopted UABA technique in 2015
and TOETVA technique in 2018. During the period from
2018 to 2019, he performed these two techniques in parallel.
Under this unique situation, this study has been conducted to
compare the outcomes of UABA and TOETVA surgeries
done by a single surgeon.
Materials and Methods
Patients
This is a prospective cohort study performed on 101 pa-
tients with thyroid diseases admitted to the Department of
Oncology and Palliative Care, Hanoi Medical University
Hospital. All cases had a preoperative diagnosis of benign
thyroid diseases, including benign thyroid nodule(s) and
Grave’s disease based on clinical examination, hormonal
level assessment, ultrasound, and puncture fine-needle aspi-
ration results.
Among 101 patients, 51 patients had TOETVA surgery
and 50 patients had UABA surgery. These two groups were
enrolled parallel in the period from 2018 to 2019, and the
surgery approach was selected based on surgeon’s choice.
This study was approved by the Institutional Review Board of
Hanoi Medical University Hospital.
Surgical procedure for UABA surgery
The surgery was performed under general anesthesia with
endotracheal intubation. The patient was placed in a supine
position with the neck extended, and the arm on the side of
the lesion was stretched at a 90angle to the axis of the body.
The surgical techniques and instruments had been described
in detail in our previous article.
7
In summary, initially,
10-mm skin incision was made at the intersection of the an-
terior axillary line and the mammary borderline to allow the
introduction of a 10 mm trocar and a cannula to create an
operating tunnel. Two other 5-mm incisions were made
along the upper edge of the ipsilateral breast areola and in
the anterior axillary line. CO
2
was insufflated to achieve a
continuous pressure of about 12 mmHg. A 5 mm hook mono-
polar and 5 mm bowel forceps were used for flap dissection
until a sufficient operative space is obtained. The anterior
border of the ipsilateral sternocleidomastoid muscle and the
strap muscles were dissected. Then, the lower pole of the
thyroid gland was identified and ligated. Thereafter, the lobe
was dissected from the trachea and the superior thyroid
pedicle was coagulated. During lobectomy procedure, the
recurrent laryngeal nerve (RLN) and parathyroid gland were
identified and preserved ( bF1
Fig. 1).
Surgical procedure for TOETVA surgery
Similar to the UABA approach, the patient was placed in
a supine position with the neck slightly extended. All patients
were put under general anesthesia with nasotracheal intuba-
tion. The oral cavity was cleaned with diluted Povidone-
iodine solution.
First, a 10 mm incision was made in the center of the lower
oral vestibule and two lateral 5 mm incisions were made 1.5–
2 cm lateral to the first incision. We then dissected along the
subplatysmal plane down to the anterior neck area using
a medium-sized Kelly clamp and 50 mL of 1:200,000
adrenaline–saline solution for hydrodissection. Then, a blunt
tip tissue dissector was inserted through the 10 mm incision
and moved in a fan shape to widen the operation space. CO
2
was insufflated at 6–8 mmHg pressure with a flow rate of
3 L/min through the 10 mm middle trocar. Two 5 mm trocars
were then introduced through the lateral incisions and the
three trocars converged at the midline. A monopolar hook
was used to complete the dissection, and the strap muscles
were dissected through the middle line to deliver the thyroid
gland into the working space. A 3/0 Vicryl silk was used to
hand up the strap muscles laterally through a transcutaneous
insertion. bAU6
The pyramidal lobe was dissected first and dis-
section was continued inferiorly to divide the isthmus. The
superior thyroid vessels were then identified and cut by a
Harmonic scalpel. Lobectomy was completed from a ceph-
alad to caudal direction and the RLN and the parathyroid
glands were preserved (Fig. 1). In cases with total thyroid-
ectomy, the procedure is repeated on the contralateral side.
The specimen was then extracted in an endobag through
the central incision. Sometimes, for large tumors, the speci-
men had to be cut into smaller pieces. This was performed
entirely within the endobag to avoid tumor cell seeding.
Afterward, the strap muscles were closed using VLOC 3/0
sutures. The oral cavity incisions were closed with Rapid 4/0
sutures.
Statistical analysis
Data were analyzed using Stata version 12. Continuous
variables were presented as mean standard deviation and
range where appropriate, and categorical variables as the
number with percentage. The means were compared using
the Mann–Whitney U test or t-test and the proportions were
compared by Fisher’s exact or chi-square test when appro-
priate. All tests were two-tailed and differences were con-
sidered statistically significant at P-values £.05.
2 NGUYEN ET AL.
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 2
Results
Clinical characteristics of study population
A total of 101 patients were enrolled in this study, in which
51 patients received TOETVA and 50 patients received
UABA thyroid surgery (
T1 cTable 1). The mean age of TOETVA
group was significantly higher than that of UABA group
(45.1 11.8 versus 34.5 8.4, P<.001). Both groups mostly
comprised women (90.2% and 96.7% respectively, P=.436)
and had comparable mean tumor diameters (22.98 8.95 mm
versus 21.82 8.82 mm respectively, P=.521).
All patients had a preoperative diagnosis of benign thyroid
diseases. However, 2 (3.9%) patients in the TOETVA group
had a final pathological result of papillary thyroid cancer.
Table 1. Patients’ Characteristics
Variables TOETVA (n=51) UABA (n=50) P
Age, mean SD (range) 45.1 11.8 (17–69) 34.5 8.4 (17–56) <.001
a
Gender, n(%)
Male 5 (9.8) 2 (3.3) .436
b
Female 46 (90.2) 48 (96.7)
Pathological diagnosis, n(%)
Benign nodule(s) 48 (94.1) 50 (100) .368
b
Papillary thyroid carcinoma 2 (3.9) 0
Grave’s disease 1 (2.0) 0
Tumor size (mm), mean SD (range) 22.98 8.95 (11–45) 21.82 8.82 (16–52) .521
c
Extent of surgery, n(%)
Total thyroidectomy 40 (78.4) 0 .001
d
Lobectomy 11 (21.6) 50 (100)
a
t-test.
b
Fisher’s exact test.
c
Mann–Whitney Utest.
d
Chi-squared test.
SD, standard deviation; TOETVA, transoral endoscopic thyroidectomy vestibular approach; UABA, unilateral axillobreast approach.
FIG. 1. (A, B) The RLN (black arrows), upper and lower parathyroid glands (yellow and white arrows, respectively) are
preserved during UABA procedure. (C, D) The RLN (black arrows), upper and lower parathyroid glands (yellow and white
arrows, respectively) are preserved during TOETVA procedure. RLN, recurrent laryngeal nerve; TOETVA, transoral
endoscopic thyroidectomy vestibular approach; UABA, unilateral axillobreast approach.
4C c
TOETVA VS. UABA FOR ENDOSCOPIC THYROIDECTOMY 3
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 3
A majority of patients in the TOETVA group (40 patients
(78.4%)) had total thyroidectomy, whereas all patients in
the UABA group had thyroid lobectomy. In total, 61 pa-
tients underwent lobectomy and 40 patients underwent total
thyroidectomy.
Surgical outcome and postoperative complications
Among patients who underwent lobectomy, the operative
time was significantly longer in the TOETVA than in the
UABA group (91.7 16.5 minutes versus 50.4 6.8 minutes,
P<.001), whereas blood loss volume was similar between
the two groups (*30 mL on average). In contrast, it took
114.4 23.2 minutes to complete a total thyroidectomy
through the transoral approach, with 58.3 9.9 mL of blood
loss. The length of hospital stay of the two groups was also
comparable (5.6 0.8 days in TOETVA versus 5.9 1.2 days
in UABA, P=.125). However, patients who had TOETVA
surgery have significantly less postoperative pain, especially
during the first 4 days (see details in
T2 cTables 2). Only 5 pa-
tients (9.8%) with TOETVA surgery and 1 patient (2%) with
UABA surgery had transient vocal cord palsy, whereas
no permanent RLN palsy was recorded in both groups.
Among 11 patients who underwent total thyroidectomy in
TOETVA, 6 (54.6%) had transient hypoparathyroidism but
fully recovered afterward. Three TOETVA patients and 1
UABA patient had postoperative mild hematoma and no
operative reintervention was required. None in both groups
had surgical site infection.
Among patients with TOETVA, 3 cases had postoperative
lower lip paresthesia that was indicative of mental nerve
injury and 3 other patients had paresthesia in the flap dis-
section area of the neck. Meanwhile, only 1 UABA patient
had paresthesia of the chest wall. Three patients in the UABA
group had swallowing limitation, whereas 1 patient in the
TOETVA group had chewing limitation. Nearly all patients
were satisfied with the cosmetic result of the operation, in
which the level of satisfaction was comparable between the
two groups (P=.617) ( bT3
Table 3). The postoperative images of
patients are presented in bF2
Figure 2.
Discussion
Our study included 101 cases of endoscopic thyroid sur-
gery performed by a single surgeon through two approaches,
TOETVA and UABA. The results showed that these two
techniques had comparable surgical outcomes including
blood loss, length of hospital stay, and were both safe treat-
ment options, as well as gave high cosmetic satisfaction.
Table 2. Surgical Outcomes of Patients Undergoing Transoral Endoscopic Thyroidectomy
Vestibular Approach Versus Unilateral Axillobreast Approach
Variables TOETVA (n=51) UABA (n=50) P
Operative time (minute)
Total thyroidectomy 114.4 23.2 (90–160) N/A
Lobectomy 91.7 16.5 (50–150) 50.4 6.8 (25–60) <.001
a
Blood loss
Total thyroidectomy 58.3 9.9 N/A
Lobectomy 30.7 6.0 29.0 4.7 .233
a
Pain score (
AU7 cVAS)
Day 1 4.6 1.0 5.8 1.0 <.001
b
Day 4 1.6 1.0 2.6 1.6 <.001
a
Day 7 0.4 0.5 0.4 0.8 .089
a
Hospital stay (day) 5.6 0.8 5.9 1.2 .125
b
Number of cases with postoperative hoarseness, n(%)
Transient 5 (9.8) 1 (2.0) .205
c
Permanent 0 0 —
Number of cases with hypoparathyroidism, n(%)
Transient 6 (11.5) 1 (2.0) .112
c
Permanent 0 N/A —
Number of cases with hematoma, n(%) 3 (5.9) 1 (2.0) .617
c
Number of cases with seroma, n(%) 6 (11.8) 0 .027
c
Number of infections, n(%) 0 0 —
Number of cases with mental nerve injury, n(%) 3 (5.9) 0 .243
c
Number of cases with paresthesia, n(%) 6 (11.8) 1 (2.0) .112
c
Number of cases with movement limitation, n(%) 1 (2.0) 3 (6.0) .362
c
a
Mann–Whitney Utest.
b
t-test.
c
Fisher’s exact test.
N
AU8 c/A; TOETVA, transoral endoscopic thyroidectomy vestibular approach; UABA, unilateral axillobreast approach.
Table 3. Cosmetic Results 3Months
After Surgery
Cosmetic
results
TOETVA (n=51),
n(%)
UABA (n=50),
n(%) P
Satisfied 50 (98.0) 48 (96.0) .617
a
Average 1 (2.0) 2 (4.0)
Dissatisfied 0 0
a
Fisher’s exact test.
TOETVA, transoral endoscopic thyroidectomy vestibular approach;
UABA, unilateral axillobreast approach.
4 NGUYEN ET AL.
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 4
However, UABA had shorter operative time, whereas
TOETVA was associated with less postoperative pain. Each
technique had its own approach-related complications de-
pending on the regional anatomy of the surgery access sites.
Hu
¨scher et al. first used endoscopic thyroid surgery in
1997.
14
Since then, many endoscopic techniques for thyroid
surgery have been developed along with the advancement of
surgical devices, which provides minimally invasive or even
scar-free surgeries for patients having cosmetic concern.
Initially, cervical approach,
15,16
parasternal approach,
17
and
breast approach
18
were used. Ikeda et al.,
19
Shimazu et al.,
20
and Lee et al.
21
then improved the technique with the axillary
and axillobilateral breast approach to minimize the visible
scar by hiding it in the axilla that can be covered completely
by the patient’s arm. However, this approach still leaves
cutaneous scars and requires a large amount of flap dissec-
tion. Therefore, several surgeons have tried the transoral
approach, first in animal models,
10
cadavers,
22,23
and then in
humans.
24
Transoral endoscopic thyroidectomy can be per-
formed through the sublingual approach, periosteal or the
oral vestibular approach, in which sublingual and periosteal
approaches cause severe tissue damage as well as high com-
plications.
25,26
In 2016, Anuwong et al. have reported en-
couraging results of TOETVA with excellent cosmetic
outcomes and minimal complications.
3
There has been ac-
cumulating evidence that demonstrated promising safety
and efficacy of TOETVA since then.
13,27,28
Compared with
UABA, TOETVA is truly scar free and patients can return to
their normal life without any concerns about scars on the
body.
In this study, the clinical characteristics of the two groups
were similar except for the mean age. The patients who un-
derwent UABA were younger than those who underwent
TOETVA. This difference is most likely due to patient se-
lection. Patients with bilateral nodularity in this study were
generally older than those with single nodule or unilateral
nodularity. A large-scale prospective cohort analysis of 6391
patients presented for evaluation of thyroid nodule(s) dem-
onstrated a 1.6% annual increased risk for multinodularity
(odds ratio, 1.02; P<.001) with advancing age.
29
In those
patients with bilateral diseases, TOETVA was used rather
than UABA since it provided the operative view and working
space for total thyroidectomy.
Among patients receiving lobectomy, the TOETVA group
had significantly longer operative time than the UABA
group. Besides, it took *25 minutes more to perform total
thyroidectomy versus lobectomy by the TOETVA approach.
A majority proportion of operative time was used for the
trocar insertion and dissection steps before thyroid dissec-
tion, and afterward, specimen extraction. This might be at-
tributable to the learning curve of our surgeon, a phenomenon
that has been encountered in other studies.
8,13
He adopted the
UABA technique in 2015 and the TOETVA technique in
2018 and these 51 cases were his initial TOETVA cases.
Hence, he was more familiar with the endoscopic view as
well as the tactics of UABA at the beginning of this study.
Notably, some patients in our cohort had a pointed chin,
which made the dissection even more difficult.
In contrast, TOETVA is associated with significantly less
operative pain than UABA in the first 4 days after surgery.
This is consistent with the findings in a study of Yang et al.
comparing the surgical outcome of TOETVA and endoscopic
thyroidectomy through the areola approach (ETAA)
30
and a
study of Chai et al. with a comparative analysis between
transoral robotic thyroidectomy and BABA robotic thyroid-
ectomy.
8
In the UABA technique, the dissection range from
the axilla and breast incisions to the thyroid gland is broader
than in the TOETVA procedure, suggesting a decrease of
surgical trauma with the TOETVA procedure. In addition, the
oral vestibule incision seems to cause less pain compared
with skin incisions.
13
Follow-up data of Yang et al. also
showed that the skin paraesthesia rate was significantly lower
in the TOETVA group than in the ETAA group 6 months
postoperation.
30
In our study, TOETVA was shown to be as safe as UABA
since there were no significant differences in estimated
blood loss or postoperative complication rates between the
two groups. However, each approach has its own approach-
related complications. For example, UABA with axillary
access can cause brachial plexus injury, shoulder dislocation,
and chest skin sensory change for several months after sur-
gery.
31,32
In contrast, TOETVA can lead to minor specific
complications such as mental nerve injury or neck skin par-
aesthesia.
13
There were no postoperative infections recorded
in our study. Given the high rate of surgical-site infections in
Vietnam,
33
we routinely gave intravenous amoxicillin with
FIG. 2. Representative examples of postoperative outcome after TOETVA (A, B) and UABA (C). TOETVA, transoral
endoscopic thyroidectomy vestibular approach; UABA, unilateral axillobreast approach.
4C c
TOETVA VS. UABA FOR ENDOSCOPIC THYROIDECTOMY 5
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 5
clavulanic antibiotic 30 minutes before skin incision and up
to 5 days after surgery. In the literature, there was only 1 case
who had an infection at the vestibular incision site 4 weeks
after surgery and required an intervention.
24
We encountered 5 cases (9.8%) with temporary RLN in-
jury in the TOETVA group and 1 case (2.0%) in the UABA
group. The complication rate in the TOETVA approach
was slightly higher than that of Anuwong et al.
3,13
and Hong
et al.
34
However, all cases fully recovered 6 months after
surgery. This may again be related to the learning curve of
the surgeon. The transient RLN injury rate might be reduced
by more meticulous dissection and by avoiding thermal in-
jury from harmonic scalpel.
13
After initial cases, we started
using a wet endoscopic gauze to reduce the heat from the
harmonic scalpel while dissecting the RLN, which improved
the rate of transient postoperative hoarseness. The rate of
hypoparathyroidism in our study was 11.5% in the TOETVA
group and 2.0% in the UABA group, which is comparable
with the results of Anuwong et al.
13
and Koh et al.
35
with the
corresponding approach. No patients were reported with
permanent hypoparathyroidism. Although the magnified
view through the endoscope may make identification of the
parathyroid glands easier, close attention must be paid to
protect the nutrient vessels when exposing the gland. None-
theless, no permanent severe complications were reported
and most patients were satisfied with the cosmetic outcome.
Our study has some limitations. First, our surgeon adopted
these two techniques at different times. Although we enrolled
patients to two groups in the same time period, the baseline
skills and experience in these two approaches did not match.
Second, patient allocation was not randomized and the
sample size was relatively small. Further study with a higher
number of patients and longer time of follow-up should be
done to thoroughly compare the safety and outcomes of these
two techniques.
Conclusions
Both TOETVA and UABA approaches have been shown
to be effective and safe surgical options for endoscopic thy-
roid surgery, as well as gave excellent cosmetic result. Each
approach has its own advantages and disadvantages, in which
UABA has shorter operative time whereas TOETVA is as-
sociated with less postoperative pain and is truly scar free.
Choice of the technique should be tailored for each individual
and patient preference should be integrated in the treatment
plan.
Disclosure Statement
No competing financial interests exist.
Funding Information
This research received no specific grant from any funding
agency in the public, commercial, or not-for-profit sectors.
References
1. Sasaki A, Nakajima J, Ikeda K, Otsuka K, Koeda K,
Wakabayashi G. Endoscopic thyroidectomy by the breast
approach: A single institution’s 9-year experience. World J
Surg 2008;32:381–385.
2. Lee KE, Kim E, Koo DH, Choi JY, Kim KH, Youn Y-K.
Robotic thyroidectomy by bilateral axillo-breast approach:
Review of 1,026 cases and surgical completeness. Surg
Endosc 2013;27:2955–2962.
3. Anuwong A. Transoral endoscopic thyroidectomy vestib-
ular approach: A series of the first 60 human cases. World J
Surg 2016;40:491–497.
4. Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama
J. Endoscopic thyroidectomy by the axillary approach. Surg
Endosc 2001;15:1362–1364.
5. Wang C, Feng Z, Li J, et al. Endoscopic thyroidectomy
via areola approach: Summary of 1,250 cases in a single
institution. Surg Endosc 2015;29:192–201.
6. Park J-O, Kim S-Y, Chun B-J, et al. Endoscope-
assisted facelift thyroid surgery: An initial experience using
a new endoscopic technique. Surg Endosc 2015;29:1469–
1475.
7. Nguyen XH, Nguyen XH, Mai TKN, Nguyen TTN, Tran
NL, Le VQ. Feasibility and safety of endoscopic thyroid-
ectomy via a unilateral axillobreast approach for unilateral
benign thyroid tumor in Vietnam. Surg Laparosc Endosc
Percutan Tech 2019;29:447–450.
8. Chai YJ, Kim HY, Kim HK, et al. Comparative analysis
of 2 robotic thyroidectomy procedures: Transoral versus
bilateral axillo-breast approach. Head Neck 2018;40:886–
892.
9. Choi JY, Lee KE, Chung K-W, et al. Endoscopic thyroid-
ectomy via bilateral axillo-breast approach (BABA):
Review of 512 cases in a single institute. Surg Endosc
2012;26:948–955.
10. Witzel K, von Rahden BHA, Kaminski C, Stein HJ.
Transoral access for endoscopic thyroid resection. Surg
Endosc 2008;22:1871–1875.
11. Miccoli P, Materazzi G, Berti P. Natural orifice surgery on
the thyroid gland using totally transoral video-assisted
thyroidectomy: Report of the first experimental results for a
new surgical method: Are we going in the right direction?
Surg Endosc 2010;24:957–958; author reply 959–960.
12. Anuwong A, Sasanakietkul T, Jitpratoom P, et al. Transoral
endoscopic thyroidectomy vestibular approach (TOETVA):
Indications, techniques and results. Surg Endosc 2018;32:
456–465.
13. Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T,
Duh Q-Y. Safety and outcomes of the transoral endoscopic
thyroidectomy vestibular approach. JAMA Surg 2018;153:
21–27.
14. Hu
¨scher CS, Chiodini S, Napolitano C, Recher A. Endo-
scopic right thyroid lobectomy. Surg Endosc 1997;11:877.
15. Yamashita H, Watanabe S, Koike E, et al. Video-assisted
thyroid lobectomy through a small wound in the subman-
dibular area. Am J Surg 2002;183:286–289.
16. Bellantone R, Lombardi CP, Bossola M, et al. Video-
assisted vs conventional thyroid lobectomy: A randomized
trial. Arch Surg 2002;137:301–304; discussion 305.
17. Shimizu K, Akira S, Jasmi AY, et al. Video-assisted neck
surgery: Endoscopic resection of thyroid tumors with a very
minimal neck wound. J Am Coll Surg 1999;188:697–703.
18. Ohgami M, Ishii S, Arisawa Y, et al. Scarless endoscopic
thyroidectomy: Breast approach for better cosmesis. Surg
Laparosc Endosc Percutan Tech 2000;10:1–4.
19. Jeong JJ, Kang S-W, Yun J-S, et al. Comparative study of
endoscopic thyroidectomy versus conventional open thy-
roidectomy in papillary thyroid microcarcinoma (PTMC)
patients. J Surg Oncol 2009;100:477–480.
6 NGUYEN ET AL.
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 6
20. Shimazu K, Shiba E, Tamaki Y, et al. Endoscopic thyroid
surgery through the axillo-bilateral-breast approach. Surg
Laparosc Endosc Percutan Tech 2003;13:196–201.
21. Lee M-C, Mo J-A, Choi IJ, Lee B-C, Lee G-H. New
endoscopic thyroidectomy via a unilateral axillo-breast
approach with gas insufflation: Preliminary report. Head
Neck 2013;35:471–476.
22. Richmon JD, Holsinger FC, Kandil E, Moore MW, Garcia
JA, Tufano RP. Transoral robotic-assisted thyroidectomy
with central neck dissection: Preclinical cadaver feasibility
study and proposed surgical technique. J Robot Surg 2011;
5:279–282.
23. Richmon JD, Pattani KM, Benhidjeb T, Tufano RP.
Transoral robotic-assisted thyroidectomy: A preclinical
feasibility study in 2 cadavers. Head Neck 2011;33:330–
333.
24. Wilhelm T, Metzig A. Endoscopic minimally invasive
thyroidectomy (eMIT): A prospective proof-of-concept
study in humans. World J Surg 2011;35:543–551.
25. Benhidjeb T, Witzel K, Stark M, Mann O. Transoral
thyroid and parathyroid surgery: Still experimental! Surg
Endosc 2011;25:2411–2413.
26. Lee HY, You JY, Woo SU, et al. Transoral periosteal
thyroidectomy: Cadaver to human. Surg Endosc 2015;29:
898–904.
27. Jitpratoom P, Ketwong K, Sasanakietkul T, Anuwong A.
Transoral endoscopic thyroidectomy vestibular approach
(TOETVA) for Graves’ disease: A comparison of surgical
results with open thyroidectomy. Gland Surg 2016;5:546–
552.
28. Sun H, Zheng H, Wang X, Zeng Q, Wang P, Wang Y.
Comparison of transoral endoscopic thyroidectomy ves-
tibular approach, total endoscopic thyroidectomy via areola
approach, and conventional open thyroidectomy: A retro-
spective analysis of safety, trauma, and feasibility of central
neck dissection in the treatment of papillary thyroid car-
cinoma. Surg Endosc 2020;34:268–274.
29. Kwong N, Medici M, Angell TE, et al. The influence of
patient age on thyroid nodule formation, multinodularity,
and thyroid cancer risk. J Clin Endocrinol Metab 2015;100:
4434–4440.
30. Yang J, Wang C, Li J, et al. Complete endoscopic thy-
roidectomy via oral vestibular approach versus areola ap-
proach for treatment of thyroid diseases. J Laparoendosc
Adv Surg Tech A 2015;25:470–476.
31. Ban EJ, Yoo JY, Kim WW, et al. Surgical complications
after robotic thyroidectomy for thyroid carcinoma: A single
center experience with 3,000 patients. Surg Endosc 2014;
28:2555–2563.
32. Kim S-J, Lee KE, Myong JP, Koo DH, Lee J, Youn Y-K.
Prospective study of sensation in anterior chest areas be-
fore and after a bilateral axillo-breast approach for endo-
scopic/robotic thyroid surgery. World J Surg 2013;37:
1147–1153.
33. Sohn AH, Parvez FM, Vu T, et al. Prevalence of surgical-
site infections and patterns of antimicrobial use in a large
tertiary-care hospital in Ho Chi Minh City, Vietnam. Infect
Control Hosp Epidemiol 2002;23:382–387.
34. Hong YT, Ahn J, Kim JH, Yi JW, Hong KH. Bi-
institutional experience of transoral endoscopic thyroidec-
tomy: Challenges and outcomes. Head Neck 2020 [Epub
ahead of print]; DOI: 10.1002/hed.26153.
35. Koh YW, Kim JW, Lee SW, Choi EC. Endoscopic thy-
roidectomy via a unilateral axillo-breast approach without
gas insufflation for unilateral benign thyroid lesions. Surg
Endosc 2009;23:2053–2060.
Address correspondence to:
Long Thanh Nguyen, MD
Department of Oncology
Hanoi Medical University
No. 1 Ton That Tung Street, Dong Da
Hanoi 100000
Vietnam
E-mail: longnguyen.hmu@gmail.com
TOETVA VS. UABA FOR ENDOSCOPIC THYROIDECTOMY 7
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 7
AUTHOR QUERY FOR LAP-2020-0272-VER9-NGUYEN_1P
AU1: Please identify (highlight or circle) all authors’ surnames for accurate indexing citations.
AU2: Please confirm the correctness of authors’ affiliations.
AU3: Please expand ‘‘VAS.’’
AU4: The Publisher requests for readability that no paragraph exceeds 15 typeset lines. Please check for long paragraphs
and divide where needed.
AU5: Please check the edit of the sentence ‘‘ This endoscopic approach provides a convenient operative space and the
small scars are easily hidden and hardly noticeable, and a preliminary report on 50 cases showed promising results
in terms of safety and patient satisfaction.’’
AU6: Please check the edit of the sentence ‘‘ The pyramidal lobe was dissected first and dissection was continued
inferiorly to divide the isthmus.’’
AU7: Please expand ‘‘VAS.’’
AU8: Please define ‘‘N/A.’’
LAP-2020-0272-ver9-Nguyen_1P.3d 05/16/20 2:39pm Page 8
... Additionally, the laparoscope provided good resolution and magnification, so the parathyroid glands were well preserved in the TT/NT/SB-D surgeries and no parathyroid glands found in these specimens. The postoperative complications and cosmetic results are also reliable in well-selected patients wishing to avoid a cervical scar 19,20 . Thus, we designed this combination of treatments to achieve optimal cosmetic results. ...
Article
Full-text available
Although the success rates of non-surgical treatments for Graves’ disease such as antithyroid medication and radioiodine ablation were good, there were still failure of treatments or intolerance for some patients. Traditional thyroid surgery could treat these patients but result in unaesthetic neck scars. Herein, we report the preliminary results of our combination of treatments with the transoral endoscopic thyroidectomy vestibular approach for Graves’ disease. A retrospective review of patients who underwent the transoral endoscopic thyroidectomy vestibular approach for the treatment of different sizes of goiters between January 2019 and December 2020 was performed. The demographic and clinical data of patients were collected. All patients were followed up for > 12 months. Each patient’s goiter size was determined using four grades—from 0 to 3. In total, 14 female patients receiving the combination treatment with > 1 year of follow-up and a median (range) age of 35 (20–48) years at surgery were included. There were two, three, four, and five patients with grade 0, 1, 2, and 3 goiters, respectively. The median (range) intraoperative blood loss was higher in grade 3 patients (100 [20–850] mL) than in grade 2 patients (20 [10–200] mL) and grade 1 and 0 patients (both < 10 mL) (p = 0.033). All patients had normal-looking necks with a euthyroid or hypothyroid status within 1 year. There were no complications, including re-operation for bleeding, hypoparathyroidism, vocal cord palsy, or infections. The designed combination treatment with the transoral endoscopic thyroidectomy vestibular approach for Graves’ disease provides optimal cosmetic results with a high success rate.
Article
Full-text available
Background In this study, we evaluate the rate of CLNM and related factors in patients with cN0 PTC undergoing transoral endoscopic thyroidectomy vestibular approach (TOETVA), a feasible and safe procedure that is widely approved for early stage PTC patients. Method A cross-sectional study was performed on 346 patients who underwent TOETVA due to thyroid cancer in the Department of Oncology and Palliative Care, Hanoi Medical University Hospital, from January 2020 to December 2021. The clinical, surgical, and pathological characteristics were recorded. Results The mean age was 36.1 ± 9.1 (13–67) years. Females accounted for 96%. Total thyroidectomy was applied in 55 cases (15.9%), and conservative thyroidectomy accounted for 291 (84.4%). The median number of harvested lymph nodes in ipsilateral and bilateral CND groups is 5 (IQR: 3–7) and 7 (IQR: 3–10). The median number of metastasized lymph nodes in these two groups is 2 (IQR: 1–3) and 3 (IQR: 2–6), respectively. The rate of CLNM was 39.9%. Thyroiditis increased the number of harvested lymph nodes: 8.3 ± 0.7 (1–24) nodes, p = 0.002. Tumor size on ultrasound, young age (<29 years old), and stage of tumor increased the possibility of CLNM, p < 0.05. Univariate and multivariate logistic regression revealed that young age (<29 years old) and gross tumor invasion were independent risk factors of high number of CLNM with p < 0.05. Conclusion In summary, CLNM rate in patients with cN0 PTC accounted for 39.9%. With the facilities of pCND by TOETVA, a procedure that is widely approved for early PTC and has excellent cosmetics and oncological results, pCND should be considered in patients with risk factors like young age or large tumor. High volume of CLNM is associated with young age and gross tumor extension, and total thyroidectomy should be indicated in these patient groups.
Article
Purposes Minimally invasive thyroid surgeries are universally accepted. We report on one, transoral endoscopic thyroidectomy with or without central neck dissection. Methods A case series of 103 patients were operated on between December 2018 and December 2021. We performed transoral endoscopic thyroidectomy vestibular approach (TOETVA) for 76 patients with a benign nodule, and 27 with papillary thyroid carcinoma (PTC). The patients with malignant nodules also underwent ipsilateral central neck dissection. The extent of surgery, operative time and operative complications were analyzed. Result No cases were converted to open surgery. Average tumor size was 3.8 ± 1.62 cm, mean operative time was 116.5 ± 41.7 min, median blood loss 40.1 ± 49 mL. There were 95 patients with lobectomy and 8 patients with total thyroidectomy. Temporary hoarseness occurred in 9 patients (8.7 %). No patients developed permanent hoarseness. Twelve patients had middle chin numbness. Conclusion The transoral endoscopic thyroidectomy vestibular approach, with or without central neck dissection, is a safe, effective and highly aesthetic treatment.
Article
Background: The transoral endoscopic thyroidectomy by vestibular approach (TOETVA) has been developed for papillary thyroid carcinoma (PTC) treatment with satisfactory results. However, there were few malignant thyroid nodules ≥2 cm in previous studies of TOETVA. Therefore, we conducted this study to evaluate the results of treatment by TOETVA for PTC with tumor size ≥2 cm. Materials and Methods: The clinical characteristics and surgical outcomes of 10 PTC patients with tumor size ≥2 cm who underwent TOETVA in our center from June 2018 to August 2021 were, respectively, reviewed. Results: All 10 included PTC patients successfully underwent TOETVA and the mean tumor size was 2.5 ± 0.5 cm. The mean number lymph nodes dissected was 9.6 ± 2.9, and 3.1 ± 3.3 positive lymph nodes were discovered. Postoperatively, transient hypoparathyroidism was recorded in 2 patients (20%), transient recurrent laryngeal nerve injury was noted in 1 patient (10%), transient superior laryngeal nerve injury was noted in 1 patient (10%), and numb chin was identified in 1 patient (10%). The postoperative complications aforementioned recovered within 6 months. During a median follow-up of 23.8 ± 13.1 months, no other complications or tumor recurrence were found. Conclusions: TOETVA is feasible for PTC patients with tumor size ≥2 cm and satisfactory short-term surgical outcomes have achieved in this study. We suggested that experienced surgeons can gradually expand the indications for TOETVA.
Article
Full-text available
Background: It has been widely assumed that TOETVA has demonstrated a new technique and a promising approach as it is both minimally invasive and optimally cosmetic. The objective of this study was to assess the surgical outcome, aesthetic satisfaction, and postoperative quality of life of TOETVA in comparison with open thyroid surgery. Patients and Methods. The study was designed as a prospective study, in which 121 patients from a single center in Vietnam underwent thyroid surgery, and the study was divided into two groups: 60 patients in the TOETVA group and 61 patients in the open surgery group. The patients have been followed up including surgical outcomes, cosmetic satisfaction, and quality of life. These criteria were assessed at 4 weeks, 8 weeks, and 12 weeks after the surgery using SF-36 and thyroid surgery-specific questionnaire. Results: Patients in the TOETVA group are significantly younger than patients in the open surgery group (35.8 + 10.3 vs 46.9 + 11.5, p < 0.001). The mean operating time was longer in the TOETVA group (102.9 ± 26.1 mins) than that in the open surgery group (66.8 ± 23.8 mins) with p = 0.0001. Cosmetic outcomes and overall satisfaction were significantly greater in the TOETVA group p = 0.0001. The SF-36 QOL scores of the patients in the TOETVA group were generally higher than the open surgery group. Conclusions: TOETVA has been widely used with a low complication rate, cosmetic appeal, and surgical efficacy. Postoperative quality of life, cosmetic outcomes, and overall satisfaction were significantly superior to the open surgery group.
Article
Full-text available
Background This study aimed to evaluate the feasibility and safety of the trans-oral endoscopic thyroidectomy vestibular approach (TOETVA) with neuroprotection techniques for the surgical management of papillary thyroid carcinoma (PTC). Methods Patients with PTC who underwent TOETVA between December 2016 and July 2020 were included in this study, and their relevant clinical characteristics, operational details, and surgical outcomes were reviewed and extracted from their medical records for further analysis. Results A total of 75 patients successfully underwent TOETVA with zero conversions. Unilateral lobectomy with isthmectomy and total thyroidectomy were completed for 58 and 17 patients, respectively, all using our unique neuroprotective procedure and ipsilateral central neck dissection (CND). The mean number of retrieved lymph nodes versus positive lymph nodes was 6.8 ± 3.7 vs. 1.5 ± 2.3. Postoperative complications included three cases of transient superior laryngeal nerve (SLN) palsy (4.0%), five cases of transient recurrent laryngeal nerve (RLN) palsy (6.7%), 14 cases of transient hypoparathyroidism (18.7%), two cases of numb chin (2.7%) and two cases of flap perforation (2.7%). The follow-up period for patients with PTC lasted for 15.6 ± 10.9 months, during which no other complications or tumor recurrence were observed. Conclusion TOETVA can be safely performed for patients with PTC with satisfactory results during the short-term follow-up period. Our neuroprotection techniques can be integrated into TOETVA, which is worth recommending for PTC patients who desire better cosmetic surgical outcomes.
Article
Full-text available
Background: In the modern era, minimally invasive surgery is rapidly evolving and even replacing conventional open techniques in many surgical fields. Thyroidectomy was not an exception, with the introduction of multiple endoscopic thyroidectomy techniques. Trans-oral endoscopic trans-vestibular thyroidectomy (TOT) is a novel technique with promising outcomes. We conducted this meta-analysis to compare surgical outcomes and learning curves for TOT and other endoscopic thyroidectomy techniques. Methods: A systematic review in PubMed, MEDLINE, and EMBASE databases was conducted searching for publications on TOT versus trans-axillary thyroidectomy (TAT). The primary endpoint was operative (OR) time. Secondary endpoints were number of harvested lymph nodes (LNs), estimated blood loss (EBL), recurrent laryngeal nerve (RLN) injury, hoarseness, seroma, infection, chyle leak, hypocalcemia, hospital length of stay (LOS), and Cost. We also investigated the learning curve for each technique. Leave-out-out analysis, meta-regression, and subgroup analysis were used. Random effect inverse variance method was utilized. Results: Among 3820 retrieved studies, 15 studies (10 unmatched and 5 matched), with 2173 (TOT: 1024(47.12%) and TAT:1149(52.87%)) patients, met the inclusion criteria. The operative time and harvested L. Ns number were higher in TOT versus TAT (standard mean difference (SMD) = 0.72 [95%CI 0.07; 1.37], P = 0.029 and SMD = 0.32 [95%CI 0.02; 0.62], P = 0.036 respectively) while less EBL in TOT versus TAT (SMD = -0.26 [-0.43; -0.09], P = 0.0018). All other outcomes showed no significant difference between both groups. Weighted mean values for TOT and TAT were 158.03 vs 144.97 min for OR time, 6.33 vs 5.16 for harvested LNs, and $5,919.05 vs $6,253.79 for the cost. Statistical significance in learning curve development was noticed ranging between 6 and 15 annual cases. Conclusion: Trans-oral thyroidectomy is a safe and reliable technique with outcomes comparable to other endoscopic techniques. It provides better access to the central compartment with a more feasible LN dissection. Improvement in surgical outcomes is expected with growing learning curve and technique mastery.
Article
Background The IDEAL Framework is a scheme for safe implementation and assessment of surgical innovation. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a new innovation in thyroid surgery that eliminates the need for a cervical incision. Despite considerable interest and adoption worldwide, significant scepticism remains regarding the outcomes and cost-effectiveness for healthcare systems. The aim of this narrative review was to appraise the available literature and examine whether TOETVA has progressed in line with the IDEAL Framework. Methods A literature review of PubMed with a focus on historical and landmark studies was undertaken to classify the evidence according to the different stages of the IDEAL Framework. Results Several different transoral approaches were developed by a small of number of surgeon-innovators on animals and cadavers, and subsequently in first-in-human studies. The trivestibular approach emerged as the safest technique, with further refinements of this technique culminating in TOETVA. The basic steps and indications for this technique have been standardized and it is now being replicated by early adopters in many centres worldwide. The development of TOETVA has closely aligned with the IDEAL Framework, and is currently at stage 2B (Exploration). Conclusion There is need for multi-institutional collaborations and international registry studies to plan high-quality randomized trials comparing TOETVA with other remote-access approaches and collect long-term follow-up data. In countries where TOETVA has yet to be adopted, the IDEAL Framework will be a useful roadmap for government regulators and professional societies to evaluate, regulate, and provide best practice recommendations for the adoption of this technique.
Article
Full-text available
Background: Transoral endoscopic thyroidectomy vestibular approach (TOETVA) has become increasingly popular in the surgical treatment of thyroid cancer. However, its application in T3b disease has not been well-defined. Methods: We conducted a quasi-experimental study on patients with an intraoperative diagnosis of T3bN0M0 differentiated thyroid carcinoma from January 2019 to January 2021 in our institution. Surgical and early oncological outcomes were assessed. Results: Among 326 patients who underwent TOETVA for thyroid cancer, 12 cases had T3bN0M0 disease intraoperatively. The mean operation time was 136.67±7.32 minutes, with 7.17±0.83 mL of blood loss. No patients reported symptoms of postoperatively transient hypoparathyroidism, mental nerve, or recurrent laryngeal nerve injury. After radioactive iodine therapy, all patients had undetectable thyroglobulin, negative antithyroglobulin, and normal neck ultrasound. Conclusions: TOETVA seems to be a surgically and oncological safe method for differentiated thyroid cancer patients with small tumors invading strap muscle intraoperatively. The patients can be well-managed with endoscopic total thyroidectomy and postoperative radioactive iodine therapy. Further studies with a larger sample size and longer follow-up are needed to provide more solid evidence.
Article
Full-text available
Background The transoral endoscopic thyroidectomy by vestibular approach (TOETVA) has been developed for early-stage thyroid cancer treatment as well as benign thyroid nodules worldwide including Viet Nam, with low rate of complications and excellent results. However, there has not been any comprehensive studies with a large number of patients and long-term follow-up in our country. Therefore, we conducted this study to evaluate the results of treatment by TOETVA for benign and malignant lesions of thyroid gland in Viet Nam. Methods A prospective study was performed on 326 eligible patients who underwent TOETVA due to thyroid cancer and benign thyroid nodules in Department of Oncology and Palliative Care, Hanoi Medical University Hospital from July 2018 to April 2021. The clinical, surgical, and pathological characteristics, postoperative complications, and visual analog scale (VAS, 0–10 cm) score in day 1, 4, and 7 after surgery, long-term oncological and surgical outcomes were recorded. Results The mean age was 36.9 ± 9.8 years. 231 patients (70.9%) were diagnosed with differentiated cancer and 95 patients (29.1%) were diagnosed benign tumors of thyroid gland. In the cancer group, 12 patients (5.2%) undergone TOETVA had T3b-intraoperative-stage diagnosis, 219 patients (92.2%) were diagnosed T1 according to AJCC 8th. After 1 month of surgery, among thyroid cancer patients, there was no abnormality reported by thyroid scintigraphy and neck ultrasound as well as in unstimulated-Tg and anti-Tg values. The mean number lymph-node dissected in the cancer group was 6.1 ± 4.1 (range 0–21 nodes). However, only 2.6 ± 1.8 metastasis nodes were discovered (range 1–8 nodes), and the maximum size of these nodes was less than 2 mm. 81 patients presented occult lymph-node metastasis among thyroid cancer patients with cN0 stage (account for 35%). The occult lymph-node metastasis was 34.2% and 50% in patients diagnosed with T1 and T3b groups, respectively. The median postoperative hospital stay was 5.4 ± 0.7 days. Postoperatively, transient hypoparathyroidism was recorded in 12 patients (4.8%), transient hoarse was noted in 9 patients (3.6%), and numb chin was identified in 7 patients (2.8%). No permanent complication was noted. VAS score on first postoperative day was 4.5 ± 0.8. Median follow-up time was 12 (3–25) months. No recurrence was recorded. Conclusions TOETVA is an innovative and revolutionary technique in the treatment of benign thyroid nodules, as well as early-stage differentiated thyroid cancer. The results of oncology, postoperative complications, and satisfied outcomes supported the wide application of TOETVA in Viet Nam.
Article
Full-text available
Background Transoral endoscopic thyroidectomy using the vestibular approach (TOETVA) is a novel technique for thyroid cancer surgery. We aimed to review our initial experiences with TOETVA for the management of thyroid carcinoma, using retrospective analyses of a larger single-center case series. Methods From September 2016 to April 2018, 132 patients with thyroid cancer underwent TOETVA. A three-port technique through the oral vestibule was used to perform endoscopic thyroidectomy with ipsilateral central compartment dissection using conventional laparoscopic instruments, and an endoscopic retractor that we developed. Results All patients had papillary thyroid carcinoma. Less-than total or total thyroidectomy with ipsilateral central compartment node dissection was performed (124 vs. 8). The mean operation time was 87.6 min (range 56–213 min). The average number of lymph nodes resected was 2.6 (range 1—12). Six patients experienced transient hoarseness, which was resolved within 3 months. Most of the patients were discharged within 3 days after surgery. Conclusions In this large series from a single center, we found that TOETVA with the endoscopic retractor can be performed safely and radically in selected patients with thyroid cancer.
Article
Full-text available
The purpose of this research study was to assess the safety and surgical outcomes of endoscopic thyroidectomy applied via a unilateral axillobreast approach with CO2 insufflation to one-sided benign thyroid tumors in Vietnam. Only 1 patient of the 50 (2%) had a postoperative hematoma at the surgery site. Open surgical conversions did not occur. The duration of postoperative drainage was from 3 to 8 days, or 4.86±1.24 days on average. The length of stay in the hospital after surgery was 4 to 9 days, or 5.9±1.2 days on average. The postoperative pain in the first postoperative days was lower in intensity compared with open surgeries. The given method provided better results in terms of patient satisfaction with the cosmetic effect of the surgery compared with up-front surgery, minimally invasive video-assisted thyroidectomy, and endoscopic procedures via the breast approach, and 96% of patients were completely satisfied.
Article
Full-text available
Background Transoral endoscopic thyroidectomy vestibular approach (TOETVA) and total endoscopic thyroidectomy via areola approach (ETA) are commonly used endoscopic thyroidectomy approaches. This study compares the effectiveness of these approaches with conventional open thyroidectomy (COT) in terms of safety, associated trauma, and feasibility of central neck dissection in the treatment of papillary thyroid carcinoma (PTC). Methods This retrospective study included patients who underwent TOETVA (n = 100), ETA (n = 119), and COT (n = 289). All patients had a pathological diagnosis of PTC and underwent unilateral lobectomy and central neck dissection. We analyzed operative time, postoperative drainage volume, postoperative C-reactive protein (CRP), preoperative and postoperative white blood cell (WBC) count and parathyroid hormone (PTH) levels, parathyroid damage, hoarseness, total number of central lymph nodes, and number of metastatic central lymph nodes. Results The clinical characteristics across the three groups were similar except for patient sex and age. There was a higher proportion of young women in the TOETVA and ETA groups than in the COT group. There were significant differences between the three groups regarding operative time (P = 0.000), postoperative drainage volume (P = 0.000), postoperative CRP (P = 0.000), ∆WBC (P = 0.000), and length of postoperative hospital stay (P = 0.021); in the TOETVA and ETA groups, operative time (P = 0.445), postoperative drainage volume (P = 0.677), and length of postoperative hospital stay (P = 0.145) were not significantly different. The percentage of cases with parathyroid gland damage (P = 0.459) and hoarseness (P > 0.05) was similar in all groups. All three procedures were efficient in performing a central lymph node dissection. Conclusions Although considered more traumatic, TOETVA and ETA are both safe treatment options for PTC. They can both achieve similar therapeutic effects of central neck dissection in the treatment of PTC when compared with open surgery.
Article
Full-text available
Background Transoral endoscopic thyroid surgery vestibular approach (TOETVA) is a promising technique involving no skin incision. Since its first use in 60 patients in 2015, TOETVA has been adopted by several hospitals worldwide. However, reports of TOETVA for thyroid cancer are scarce. Methods Between August 2016 and March 2019, 150 and 125 thyroid cancer patients underwent TOETVA and open thyroidectomy (OT), respectively, by a single endocrine surgeon. Comparative analyses were performed on clinical and pathological findings, complications, and surgical completeness in total thyroidectomy cases, as indicated by the serum thyroglobulin (Tg) level. Data were collected prospectively and analyzed retrospectively. Results Mean age was younger in the TOETVA than in the OT group (43.06 ± 10.90 vs. 51.02 ± 12.42). The percentage of females was 96.7% in the TOETVA group. Total thyroidectomy was higher in the OT group (26.7% vs. 65.0%). Operation time (min) was longer in the TOETVA group for lobectomy (102.12 ± 32.59 vs. 76.38 ± 21.24) and total thyroidectomy (132.65 ± 34.79 vs. 90.71 ± 25.09). The largest tumor diameter was 0.91 (± 1.00) in the TOETVA group and 1.19 (± 1.07) in the OT group. The harvested lymph node number was not significantly different between the two groups for lobectomy (3.19 ± 2.89 vs. 3.49 ± 2.41, p = 0.319) and total thyroidectomy (4.98 ± 3.12 vs. 5.70 ± 4.35, p = 0.714). The thyroid-stimulating hormone stimulated Tg level before administration of the first dose of radioactive iodine was also not different (3.38 ± 10.87 vs. 3.44 ± 11.51, p = 0.595). Percentage of stimulated Tg below 1.0 ng/ml was 80.0% in the TOETVA group. Conclusions TOETVA is feasible in selected thyroid cancer patients, not only because it is cosmetically advantageous but also because it is oncologically safe. A large prospective cohort study including recurrence surveillance is needed to consolidate the feasibility of TOETVA.
Article
Background Transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a novel remote‐access endoscopic approach. In this study, we compared the surgical outcomes of TOETVA with those of conventional transcervical approach (TCA) in two tertiary hospitals. Methods A total of 82 patients were done by TOETVA and 233 patients received TCA between January 2018 and April 2019. Propensity score matching was used to reduce selection bias. Results Operation time of the TOETVA group was longer than that of the TCA group. The mean number or retrieved lymph nodes were significantly higher in the TOETVA group. No significant difference was observed in the overall perioperative complications. Conclusion TOETVA is technically acceptable when compared to TCA in terms of equal baseline characteristics of patients. Although future large‐scale multicenter studies with longer follow‐up periods are needed, we expect this novel technique can be performed not only for cosmetic purposes but also for patients with papillary thyroid carcinoma.
Article
Background: The 2015 American Thyroid Association (ATA) guidelines called for consideration of thyroid lobectomy (TL) as an acceptable surgical treatment for small and less aggressive papillary thyroid cancers (PTC) with no clinical evidence of metastasis or extrathyroidal extension. Optimal extent of surgery, however, remains controversial. Methods: A systematic literature review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. PUBMED, EMBASE, Scopus, and Cochrane Library databases were searched to identify studies comparing TL to total thyroidectomy (TT) for low-risk PTC. Studies were grouped according to the major outcomes in the literature: survival and the need for completion thyroidectomy (CT). Results: Overall survival for low-risk PTC patients who underwent TL was comparable to TT. Locoregional recurrence (LRR) rate following TL was less than 6% and salvaged with CT. The proportion of patients meeting the 2015 ATA guidelines selection criteria for TL who subsequently would need CT varied by study but averaged 34%. After excluding microscopic extrathyroidal extension and positive resection margin as indications for CT to facilitate radioactive iodine ablation, the estimated rate across the included studies was 11%. Conclusions: We performed a systematic review of outcomes following TL or CT for low-risk PTC according to 2015 ATA guidelines. Initial operative approach did not have a negative impact on overall survival. There is a paucity of high-quality data on this topic across the literature. Long-term follow-up studies on oncologic and patient-centered outcomes are essential.
Article
The prevalence of low-risk differentiated thyroid cancer (DTC) is dramatically increasing because of superior diagnostic imaging technologies. Remote-access endoscopic thyroidectomy is becoming more popular for the lack of a noticeable neck scar. Transoral endoscopic thyroidectomy, vestibular approach (TOETVA) is the only technique that could be called a true scarless surgery; however, there is a scarcity of long-term studies about its safety and feasibility. Because thyroid cancer is a slow-growing lesion, with adequate follow-up and surveillance, TOETVA is a surgical procedure for the management of low-risk DTC without any difference of surgical and oncological outcome.
Article
Background Endoscopic transoral thyroidectomy is a recently introduced technique of remote access thyroidectomy. We previously reported the feasibility of the robotic approach (TORT). Nevertheless, experience to date is limited, with scant data on outcomes in patients with papillary thyroid carcinoma (PTC). Methods This was a retrospective analysis of prospectively collected data. Patients with PTC, who underwent TORT at a single center between March 2016 and February 2017, were analyzed. Results There were a total of 100 patients (85 women, 15 men) with a mean age of 40.7 ± 9.8 years, and a mean tumor size of 0.8 ± 0.5 cm. Nine patients underwent a total thyroidectomy, and 91 underwent a lobectomy. The operative time for a total thyroidectomy and lobectomy was 270.0 ± 9.3 and 210.8 ± 32.9 min, respectively. Ipsilateral prophylactic central neck compartment dissection was performed routinely with retrieval of 5.0 ± 3.6 lymph nodes. Perioperative morbidity was present in nine patients including transient recurrent laryngeal nerve palsy (n = 1), postoperative bleeding requiring surgical intervention (n = 1), zygomatic bruising (n = 2), chin flap perforation (n = 1), oral commissure tearing (n = 2), and chin dimpling (n = 2). There was no conversion to endoscopic or conventional open thyroid surgery. Conclusion In this study, TORT could be safely performed in a large series of patients with PTC without serious complications. In selected patients, TORT by experienced surgeons could be considered an alternative approach for remote access thyroidectomy.
Article
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high‐quality cancer registry data, the basis for planning and implementing evidence‐based cancer control programs, are not available in most low‐ and middle‐income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1‐31. © 2018 American Cancer Society